Multicell Technologies Stock

Multicell Technologies Working Capital

The Working Capital of Multicell Technologies (MCET) as of Aug 4, 2026 is -1.06 M USD. In the previous year, Working Capital was -1.10 M USD — a change of -4.08% (higher).

Working Capital

-1.06 MUSD

YoY

-4.08%

Last updated:

Working Capital of Multicell Technologies is 2026 -1.06 M USD. Working Capital of Multicell Technologies was 2025 -1.10 M USD. It decreases by -4.08% higher compared to the previous year.
Access this data via the Eulerpool API

Multicell Technologies Stock analysis

What does Multicell Technologies do? Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field. Multicell Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Multicell Technologies stock

Working Capital of Multicell Technologies is -1.06 M USD in 2026.

Working Capital of Multicell Technologies changed from -1.10 M USD to -1.06 M USD, representing a -4.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Multicell Technologies since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Multicell Technologies historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Multicell Technologies

All Key Metrics — Multicell Technologies